Letrozole Intermediate Powder , For Commerical

Letrozole is a White to yellowish, crystalline powder and used as an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.NAME OF PRODUCT : Letrozole IntermediateCAS NO112809-51-5Chemical FormulaC17H11N5MOL. WEIGHT285.303 G/Mol About the Company GST Registration Date: 2017 Legal Status of Firm: Limited Company Number of Employees: 11 To 25 People Annual Turnover: 5 - 25 Cr company-description: Incorporated in the year 2007, under the visionary Mr. Sanjay Totre, today Yashica Pharmaceuticals has evolved as a pioneer in pharmaceutical drugs worldwide. The quality range of our products includes Active Pharmaceutical Ingredient (API) and Pharmaceutical Intermediates. These are manufactured as per the international standards & meet all regulation of pharmaceutical and chemical industries. With the help of our sound manufacturing facility, we are able to prepare a highly effective range of products. Our professional approach has helped us in maintaining the trust of our clients.